Vimarsana
Biggest News Aggregation in the World

Page 24 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

Merck's blood vessel disorder drug succeeds in late-stage study - Vimarsana News

Merck's blood vessel disorder drug succeeds in late-stage study

(Reuters) -Merck & Co said on Monday an experimental treatment it gained through its $11.5 billion deal for Acceleron Pharma met the main goal of a st...

Source: whbl.com
Merck Reports Positive Phase 3 Results for Sotatercept in Pulmonary Arterial Hypertension - Vimarsana News

Merck Reports Positive Phase 3 Results for Sotatercept in Pulmonary Arterial Hypertension

By Colin Kellaher Merck & Co. on Monday said a Phase 3 study of its sotatercept drug candidate met the key goals as an add-on to stable background therapy for pulmonary arterial... | October 10, 2022

Why Horizon Therapeutics Is One Of The Best Investments In Biotech Today (NASDAQ:HZNP) - Vimarsana News

Why Horizon Therapeutics Is One Of The Best Investments In Biotech Today (NASDAQ:HZNP)

Horizon Therapeutics shares are down 50% from last year's highs. See why HZNP stock is one of the best investment opportunities in biotech today.

Monoclonal Antibody Partnering Report 2022: Comprehensive Access to Available Deals and Contract Documents Since 2015 - Vimarsana News

Monoclonal Antibody Partnering Report 2022: Comprehensive Access to Available Deals and Contract Documents Since 2015

/PRNewswire/ -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering. The...

Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q2 2022 Results - Earnings Call Transcript

Albireo Pharma, Inc. (NASDAQ:NASDAQ:ALBO) Q2 2022 Earnings Conference Call August 15, 2022, 16:30 ET Company Participants Hans Vitzthum - LifeSci Advisors Ron Cooper - CEO, President &...